This is a preview of subscription content, log in via an institution to check access.
Reference
Nagendra D, et al. Cost-effectiveness of Mifepristone Pretreatment for the Medical Management of Nonviable Early Pregnancy. Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open : 26 Mar 2020. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2020.159
Rights and permissions
About this article
Cite this article
Mifepristone "valuable addition" to early pregnancy loss management in US. PharmacoEcon Outcomes News 851, 30 (2020). https://doi.org/10.1007/s40274-020-6753-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6753-1